Home LiteratureArticle Details
PMID: 911769 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Incorporation of deoxynucleotides into DNA by diethylaminoethyldextran-treated lymphocytes.

Biochemistry ·Vol. 16 ·No. 20 ·1977-10-04 ·Pages 4470-7

Fox RM, Mynderse JF, Goulian M

Abstract

In the presence of diethylaminoethyldextran cultured human lymphocytes will utilize deoxynucleotides for the synthesis of DNA, whereas in the absence of diethylaminoethyldextran no incorporation of deoxynucleotides is detected. Labeled deoxynucleoside mono-, di-, and triphosphates are incorporated into DNA at approximately the same rate. Deoxynucleotide incorporation is essentially linear for 10 min but continues at a gradually diminishing rate for an additional 20 to 50 min. The initial rate of DNA synthesis is at least 20 to 40% of the in vivo rate, and in those cells that are in S phase 0.7-1.5% of the DNA is synthesized. By the three properties examined (restriction to S phase, semiconservative mode, and initial product in short chains), DNA synthesis in diethylaminoethyldextran-treated cells resembles DNA synthesis in vivo.

MeSH Terms
Cell Line DEAE-Dextran/pharmacology DNA/biosynthesis Deoxyribonucleotides Dextrans/pharmacology Humans Kinetics Lymphocytes/drug effects,metabolism
Chemicals
Deoxyribonucleotides Dextrans DNA DEAE-Dextran
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Fox R M
Mynderse J F
Goulian M
Article Info
Journal
Biochemistry
Abbr.
Biochemistry
ISSN
0006-2960
Published
1977-10-04
Pages
4470-7
Language
English
Region
United States
NLM ID
0370623
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com